New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 14, 2012
06:31 EDTEWEdwards Lifesciences downgraded to Sell from Neutral at UBS
UBS downgraded Edwards Lifesciences due to the slower than expected U.S. Sapien launch and European deceleration. Price target lowered to $80 from $95.
News For EW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 24, 2015
10:08 EDTEWSenate Health, Education, Labor & Pensions Committee to hold a hearing
The Committee holds a hearing entitled, "Continuing Americaís Leadership: Advancing Research and Development for Patients" with Chairman & CEO Mussallem of Edwards Lifesciences on March 24 at 10 am. Webcast Link
March 20, 2015
16:33 EDTEWStocks end week higher after market reads Fed statement as dovish
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use